New therapy prevents dangerous side effect for lymphoma patients

Patients respond well to a new three-drug combination for indolent B cell lymphoma that also spares them prolonged, potentially lethal, suppression of blood production in the bone marrow, researchers at The University of Texas M. D. Anderson Cancer Centre report at the 50th annual meeting of the American Society of Hematology...

Read the whole article on

More from